I am basing that on previous expectations here by people well above my pay grade, and numerous external forecasts.
I think the current drop is due to a combination of profit taking after recent gains and the fact many people have very short term expectations.
Where do you think it will be after FDA approval and the product in the market?
- Forums
- ASX - By Stock
- BOT
- Ann: Botanix Partners with Telehealth Provider UpScriptHealth
Ann: Botanix Partners with Telehealth Provider UpScriptHealth, page-12
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
-0.005(1.56%) |
Mkt cap ! $572.5M |
Open | High | Low | Value | Volume |
32.0¢ | 32.0¢ | 31.0¢ | $1.366M | 4.341M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 342765 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 723414 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 336540 | 0.310 |
11 | 232799 | 0.305 |
36 | 572352 | 0.300 |
6 | 120637 | 0.295 |
7 | 148067 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 623414 | 17 |
0.325 | 258370 | 4 |
0.330 | 119269 | 6 |
0.335 | 330000 | 3 |
0.340 | 409590 | 4 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online